Pregabalin Extended Release
NDC 50228-462, PREGABALIN, tablet, film coated, extended release, from ScieGen Pharmaceuticals, INC..
- Product NDC
- 50228-462
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, INC.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215675
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50228-462 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PREGABALIN82.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-462-05 | 50228046205 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-462-05) |
| 50228-462-30 | 50228046230 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-462-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1544a657-353c-47f8-96ac-a63fa78373f0
Use it
Look up 50228-462 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-462 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-462. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.